Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicola Orofino
Observed name:
N. Orofino
Institution:
Azienda Ospedaliera Ospedale Civile di Legnano
Observed institutions:
Vita-Salute San Raffaele University,
University of Milan,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Azienda Ospedaliera Ospedale Civile di Legnano,
IRCCS San Raffaele Roma,
Aziende Socio Sanitarie Territoriale Ovest Milanese
show all 6
ORCID:
0000-0003-2198-2771
Observed ORCID:
0000-0003-2198-2771
OpenAlex ID:
A5061865843
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study
2019
·
Simona Soverini
, Luana Bavaro
, et al.
·
Blood
·
113
PDF
Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?
2015
·
Alessandra Iurlo
, Emanuela Orsi
, et al.
·
Oncotarget
·
69
PDF
Combination of deferasirox and deferoxamine in clinical practice: An alternative scheme of chelation in thalassemia major patients
2014
·
E. Cassinerio
, N. Orofino
, et al.
·
Blood Cells Molecules and Diseases
·
52
Identification of kitM541L somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response
2014
·
Alessandra Iurlo
, Umberto Gianelli
, et al.
·
Oncotarget
·
42
PDF
Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study
2019
·
Nicola Stefano Fracchiolla
, Mariarita Sciumè
, et al.
·
PLoS ONE
·
36
The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations
2016
·
Umberto Gianelli
, Daniele Cattaneo
, et al.
·
Modern Pathology
·
32
PDF
A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients
2015
·
E. Cassinerio
, A. Roghi
, et al.
·
Annals of Hematology
·
31
Current and Emerging Treatment Options for Patients with Relapsed Myeloma
2013
·
Roberto Castelli
, Roberta Gualtierotti
, et al.
·
Clinical Medicine Insights Oncology
·
31
PDF
Transient elastography spleen stiffness measurements in primary myelofibrosis patients: a pilot study in a single centre
2015
·
Alessandra Iurlo
, Daniele Cattaneo
, et al.
·
British Journal of Haematology
·
30
PDF
Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda ‐ Lombardy Hematologic Network, I taly)
2017
·
Nicola Stefano Fracchiolla
, Elisabetta Todisco
, et al.
·
American Journal of Hematology
·
26
PDF
Marked eosinophilia as initial presentation of breast implant-associated anaplastic large cell lymphoma
2016
·
Nicola Orofino
, Francesca Guidotti
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
25
Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option
2018
·
Alessandra Iurlo
, Daniele Cattaneo
, et al.
·
Clinical Drug Investigation
·
23
Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients
2017
·
Umberto Gianelli
, Stefano Fiori
, et al.
·
Histopathology
·
23
PDF
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)
2025
·
Massimo Breccia
, Francesca Palandri
, et al.
·
Cancer
·
19
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline
2019
·
Monica Crugnola
, Fausto Castagnetti
, et al.
·
Annals of Hematology
·
19
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients
2018
·
Mario Tiribelli
, Massimiliano Bonifacio
, et al.
·
Oncotarget
·
19
PDF
Erdheim–Chester Disease With Multiorgan Involvement, Following Polycythemia Vera: A Case Report
2016
·
Alessandra Iurlo
, Lorenzo Dagna
, et al.
·
Medicine
·
15
Deferasirox in the management of iron‐overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda ( IRON ‐M study)
2019
·
Elena M. Elli
, Alessandra Iurlo
, et al.
·
British Journal of Haematology
·
13
Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia
2017
·
Alessandra Iurlo
, Cristina Bucelli
, et al.
·
Annals of Hematology
·
10
Anagrelide and Mutational Status in Essential Thrombocythemia
2016
·
Alessandra Iurlo
, Daniele Cattaneo
, et al.
·
BioDrugs
·
10
Erratum: The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations
2017
·
Umberto Gianelli
, Daniele Cattaneo
, et al.
·
Modern Pathology
·
9
PDF
An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review
2017
·
Nicola Orofino
, Daniele Cattaneo
, et al.
·
Leukemia Research Reports
·
9
PDF
Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)
2015
·
Nicola Stefano Fracchiolla
, Elisabetta Todisco
, et al.
·
Blood
·
7
Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib
2015
·
Alessandra Iurlo
, Daniele Cattaneo
, et al.
·
Annals of Hematology
·
7
Early detection of pulmonary hypertension in primary myelofibrosis: The role of echocardiography, cardiopulmonary exercise testing, and biomarkers
2017
·
Mariarita Sciumè
, Veronica Mattiello
, et al.
·
American Journal of Hematology
·
6
PDF
Show more works
View as search
Works count:
69
Citation count:
728
H-index:
16
I10-index:
20
Year
Topic
Type